Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The interactions between two types of quaternary ammonium surfactants (N,N,N-trimethyl-2-(dodecanoyloxy)ethaneammonium bromide (
DMM
-11) and N,N,N-trimethyl-2-(dodecanoyloxy)propaneammonium bromide (DMPM-11)) and hen egg white
lysozyme
were studied through several techniques, including isothermal titration calorimetry (ITC), circular dichroism (CD) and fluorescence spectroscopy, and surface tension measurement. The average number of surfactants interacting with each molecule of
lysozyme
was calculated from the biophysical results. Moreover, the CD results showed that the conformation of
lysozyme
changed in the presence of
DMM
-11 and DMPM-11. The studies drew a detailed picture on the physicochemical nature of interactions between both surfactants and
lysozyme
. Both
DMM
-11 and DMPM-11, with and without
lysozyme
were studied against three target microorganisms, including Gram-negative (Escherichia coli) and Gram-positive (Enterococcus hirae and Enterococcus faecalis) bacteria. The results revealed a broad spectrum of antibacterial nature of surfactant/
lysozyme
complexes, as well as their effect on the membrane damage, hence providing the basis to further explore
DMM
-11 and DMPM-11 combined with
lysozyme
as possible antibacterial tools.
...
PMID:Synergistic effect of hen egg white lysozyme and lysosomotropic surfactants on cell viability and membrane permeability. 3168 5